MLAB (Mesa Laboratories) Short-Term Debt: $5.6 Mil (As of Mar. 2026)


MLAB Mesa Laboratories Inc MLAB
77 GF Score
Price $105.39
GF Value $116.17
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Mesa Laboratories Short-Term Debt?

Mesa Laboratories MLAB +1.10% 77 Short-Term Debt is $5.6 Mil as of Mar. 2026. GuruFocus rates MLAB with a GF Score™ of 77/100 and a GF Value™ of $116.17 (Fairly Valued). The stock has 8 warning signs investors should review.

Mesa Laboratories's Short-Term Debt for the quarter that ended in Mar. 2026 was $5.6 Mil.

Mesa Laboratories's quarterly Short-Term Debt increased from Sep. 2025 ($4.7 Mil) to Dec. 2025 ($5.2 Mil) and increased from Dec. 2025 ($5.2 Mil) to Mar. 2026 ($5.6 Mil).

Mesa Laboratories's annual Short-Term Debt increased from Mar. 2024 ($0.0 Mil) to Mar. 2025 ($101.0 Mil) but then declined from Mar. 2025 ($101.0 Mil) to Mar. 2026 ($5.6 Mil).

Mesa Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Mesa Laboratories Short-Term Debt Related Terms

Mesa Laboratories Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Mesa Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mesa Laboratories Short-Term Debt Chart

Mesa Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 101.05 5.63

Mesa Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.05 101.65 4.69 5.16 5.63
MLAB
77GF Score
Mesa Laboratories Inc MLAB
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $5.6 Mil mean?
Mesa Laboratories (MLAB) has a Short-Term Debt of $5.6 Mil as of Mar. 2026.
Is Mesa Laboratories' Short-Term Debt too high?
Mesa Laboratories' current Short-Term Debt is $5.6 Mil. Overall, Mesa Laboratories has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Short-Term Debt compare to AERG and USBC?
Mesa Laboratories' Short-Term Debt of $5.6 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Hardware company?
A good Short-Term Debt depends on the Hardware industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Mesa Laboratories's current Short-Term Debt is $5.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Fairly Valued. The stock's GF Value™ is $116.17, compared to a current price of $105.39 — trading 9.3% below its estimated fair value. The current Short-Term Debt is $5.6 Mil. Mesa Laboratories' overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Short-Term Debt is $5.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mesa Laboratories (MLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Mesa Laboratories stock appears to be undervalued. The current stock price of $105.39 is trading 9.3% below its estimated GF Value™ of $116.17. GuruFocus considers Mesa Laboratories to be Fairly Valued.

Key valuation signals for MLAB:

  • Short-Term Debt: $5.6 Mil
  • GF Value™: $116.17 vs. price of $105.39 (9.3% below fair value)
  • GF Score™: 77/100 with 8 warning signs

No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mesa Laboratories Business Description

Address 12100 West Sixth Avenue, Lakewood, CO, USA, 80228
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
77GF Score

Get the complete analysis for MLAB

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$105.39
Price
$116.17
GF Value